Sinobiomed will conduct the trial in collaboration with Mahidol University in Bangkok, Thailand. The study site is located in Thailand’s Ratchaburi Province, approximately 200km from Bangkok near the
T Baugh III, managing director of Bourne Partners, has been named CEO of Theramed. Concurrent with the acquisition of Theramed, Bourne Partners has assigned its exclusive right to
The trial is designed to assess the safety and pharmacokinetics of a single intravenous infusion of recombinant human plasma gelsolin (rhu-pGSN) in critically ill patients with profound hypogelsolinemia
The agreement includes an exclusive license to data from a planned study intended to provide long-term follow-up on the hearing status, disease-free status and overall survival of patients
The FDA approved Treximet for the acute treatment of migraine attacks, with or without aura, in adults on April 15, 2008. Treximet will be commercialized by GlaxoSmithKline.
Noninvasive total hemoglobin will be offered as part of the upgradable Masimo Rainbow SET technology platform. The Masimo Rainbow SET platform allows clinicians to noninvasively and continuously measure
The lawsuit is in response to an abbreviated new drug application filed by Novel with the FDA regarding Novel’s intent to market a generic version of Moviprep in
The study is designed to determine whether Agilus is superior to saline-control in reducing the debilitating pain associated with ankle osteoarthritis (ankle OA). If Agilus is proven to
Two recently published Phase II studies demonstrated the safety and performance of Versiva XC Gelling Foam Dressings as part of a protocol of care in promoting wound healing
Under the agreement, Mindray has acquired Datascope’s patient monitoring device business for a total purchase price of $209 million in cash, as adjusted for working capital at the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.